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Introduction: The activity and regulation of inflammasome is receiving increasing
attention in septic shock. Moreover, there is a growing body of evidence suggesting
that mitochondrial DNA (mtDNA) can play a role as biomarker of disease severity and
even mortality both in adults and children in critically ill setting. However, no data are
available on the amount of circulating mtDNA and inflammasome gene expression in
multi-drug resistant (MDR) bacteria septic shock. For this reason, the aim of this study
was to determine whether plasma mtDNA levels and inflammasome gene expression in
monocytes could be related to severity in patients admitted to intensive care unit (ICU)
with septic shock due to MDR pathogens.
Materials and Methods: Peripheral blood mononuclear cells (PBMC) and plasma were
isolated from up to 20 ml of venous blood by density gradient centrifugation in patients
admitted to ICU with the diagnosis of septic shock due to MDR-bacteria. Then, CD14+
monocytes were sorted, and RNA and DNA were extracted. NLRP3, PYCARD, AIM2
and NAIP expression level was analyzed by RT-PCR. Plasma circulating mtDNA levels
were quantified by digital droplet PCR. Basal and outcome characteristics of the patients
were collected. Age-matched healthy subjects were chosen as controls.
Results: Nineteen patients with septic shock and 20 healthy subjects were enrolled
in the study. A small trend toward an increased expression of inflammasome genes
was observed in septic shock patients, who also displayed a marked tendency to
an increased expression of IL-18 and IL-1β genes. Circulating mtDNA levels were
significantly higher in septic shock patients if compared to healthy subjects, and patients
who died in ICU were characterized by higher level of mtDNA if compared to those
who were dismissed after 7 days. No correlations were found between mtDNA and
inflammasome level and other clinical variables.
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Conclusion: Despite many limitations, our data suggest that in patients with septic
shock caused by MDR pathogens the expression of main inflammasome genes was
comparable to that of healthy patients without infection. Furthermore, our data evidence
a possible role of mtDNA as a prognostic marker of severity in septic shock from MDR.
Keywords: septic shock, circulating mtDNA, multidrug resistance bacteria, inflammasome, intensive care unit
INTRODUCTION
Septic shock still represents the pathology with the highest
risk of mortality worldwide despite the knowledge and
attention dedicated to this disease over the past 20 years.
Recent investigations of the pathogenic host response to
infection have highlighted a different behavior depending
on whether there is a hyperinflammatory state or a hypo-
reactivity of the immune system (1). These new perspectives
have brought up the role of pathogen-associated molecular
patterns (PAMPs) and danger-associated molecular patterns
(DAMPs) in the initiation and propagation of the inflammatory
cascade. This “Danger Model” stipulates that when cells are
injured they release their components into the extracellular
space, which in turn drives an immune or inflammatory
response (2). Inflammasomes, such as NLRP3, PYCARD,
AIM2, and NAIP are multimeric protein complexes that
serve as important cytosolic pattern recognition receptors
required for recognizing DAMPs and PAMPs. The activation
of inflammasome signaling pathways is involved in mounting a
proinflammatory immune response by regulating the maturation
from precursors of IL-1β, IL-18, IL-33, cytokines that can
induce pyroptosis. Recently, mitochondrial DAMPs have been
identified as important mediators of the innate immune response
and implicated in various conditions such as trauma, sepsis,
and autoimmune disorders [reviewed in (3)]. Accordingly, the
ability of mitochondrial (mt) DNA to act as DAMPs in the
activation/inhibition of the inflammatory cascade has been
recently investigated (4, 5). In critically ill setting, mainly in
septic shock patients, there is a growing body of literature
suggesting that mtDNA plasma levels can probably be used as
biomarker of disease severity and even mortality both in adults
and children (6–8).
The role of inflammasome and mtDNA is a research field
that is receiving more and more attention in septic shock,
but, to our knowledge, no data exist on these two parameters
during multi drug resistant (MDR)-bacteria septic shock. For
this reason, we investigated whether plasma mtDNA levels and
inflammasome gene expression in monocytes, cells that are
crucial for innate immune response, could be related to severity
in patients admitted to intensive care unit (ICU) with septic shock
due to MDR pathogens infection.
MATERIALS AND METHODS
Patients’ Population and Selection
We performed a prospective observational study in the ICU of
the University Hospital Policlinico of Modena (Italy) between
April 2014 and December 2018. Evaluation of entry criteria and
subsequent enrollment in the study occurred during planned
routine patients visits. Inclusion criteria were: patients aged
18 years or older admitted to our ICU with septic shock
sustained by documented MDR bacteria. Definitions of septic
shock and MDR bacteria are detailed in a previous report (9).
Patients with autoimmune or hematologic disease, pregnancy,
metastatic cancer, end-stage liver disease, end-of-life decisions,
illnesses or with medications known to be toxic to mitochondria
were excluded. The type of admission, relevant pre-existing
diseases, the primary site of infection, microbiology lab results,
SOFA scores when sepsis was diagnosed were collected. Age-
matched healthy subjects without infections were chosen as
controls (CTR). Blood from patients with septic shock was
sampled from the arterial catheter within 24 h from the
diagnosis of septic shock. The study was carried out in
accordance with recommendations of the Prot. n 2630/CE
approved by the Province of Modena Ethical Committee. All
subjects gave written informed consent in accordance with the
Declaration of Helsinki.
Biological Sample Collection, Processing
and Storage
Peripheral blood mononuclear cells (PBMC) and plasma were
isolated from up to 20 ml of venous blood by density gradient
centrifugation, using standardized protocols and Lymphoprep
reagent from Stemcell (Cambridge, MA, United States). Plasma
was then stored at −80◦C until use (10). A minimum of 1.5
million CD14+ monocytes were sorted starting from 20 million
PBMC through immunomagnetic separation technique (Miltenyi
Biotec, Bergish Gladbach, Germany). Purity of monocyte
population was always>95%.
RNA Extraction, Reverse Transcription
RNA was extracted from CD14+ cells through Quick-RNA
Miniprep Kit (Zymo Research, Irvine, United States) and
quantified using NanoPhotometer NP80 (Implen, Munich,
Germany). Then, 20 ng/µl of RNA was reverse transcribed
with the iScript cDNA Synthesis kit (Bio-Rad, Hercules,
CA, United States).
Pre-amplification and Real-Time
Polymerase Chain Reaction (PCR) for
Gene Quantification
In order to obtain a more accurate RNA quantification,
cDNA samples were pre-amplified using Sso Advanced PreAmp
Supermix (Bio-Rad). Quantification of inflammasome genes was
performed by Real-Time PCR as previously described (11).
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Changes in genes expression between the two groups of patients
were calculated through the11 cycle method.
DNA Extraction and Digestion
DNA was extracted from plasma samples using QIAmp DNA
Mini Kit (QIAGEN, Venlo, Netherlands) and then digested with
BamHI enzyme. The reaction mix was prepared as follows: 1 µl
BamHI enzyme, 1 µl Buffer Fast Digest, 6 µl DNA, in a total
volume of 10 µl. Samples were then incubated in C1000 Touch
Thermal Cycler (Bio-Rad) for 5 min at 37◦C followed by 5 min
at 80◦C.
Total Quantification of mtDNA
Circulating in Plasma Using Droplet
Digital PCR
Quantitative real-time PCR (qPCR) is often used for the detection
of nucleic acid in research and diagnostic, but the methodology
has several limitations, first of all the need of preparing dedicated
standard curves. Thus, we have used droplet digital PCR (ddPCR)
to quantify circulating mtDNA because there is no need of a
standard curve, and because the results are less dependent from
the efficiency of the reaction. The sample is indeed partitioned
in droplets and each of them represents an isolated end-point
PCR reaction. The frequency of positive to negative droplets in
the reaction mixture thus allows a precise quantification of the
concentration of target nucleic acids (12).
Before performing ddPCR, samples were diluted 1:10 in
order to obtain more accurate results. Two different assays
were performed in this set of experiments: ddPCR assay
EIF2C1 (UniqueAssayID: dHsaCP2500349, Bio-Rad) (HEX
fluorescence) for genomic DNA and ddPCR assay MT-ND4
for mtDNA (UniqueAssayID:dHsaCPE5043566, Bio-Rad) (FAM,
fluorescence). Droplet Digital PCR was performed as previously
described (12). Manufacturer’s thermal cycling protocol was
optimized, changing the annealing/extension step temperature
from 55 to 57◦C.
Statistical Analysis
Categorical (sex) and quantitative (age) variables were compared
between groups by χ2 and Mann–Whitney tests, respectively.
Differences between controls and septic shock patients were
explored with Mann–Whitney test. A P-value < 0.05 was
considered statistically significant. Data shown in graphs are
represented as the mean ± SEM. Statistical analyses were
performed using Prism 8.0 (GraphPad Software Inc., San Diego,
CA, United States).
RESULTS
Patients Characteristics
A total of 19 ICU patients with septic shock induced
by MDR pathogens were enrolled. Twenty healthy subjects
without infections (8 males/12 females, mean age ± SD,
60.8 ± 4.4 years), were chosen as CTR. ICU patients
had septic shock caused mainly by peritonitis and blood
TABLE 1 | Clinical characteristics of the 19 patients with septic shock.
Sex Male n = 12 (63.2%) Females n = 7 (36.8%)
Age [years, median (range)] 67 (33–81)
SOFA score [median (range)] 11 (7–21)
ICU mortality n (%) 10 (52.6%)
30-day mortality n (%) 8 (42.1%)
1-year mortality n (%) 12 (63.2%)
Sepsis focus*
Abdomen n (%) 9 (47.4%)
Lung n (%) 4 (21.1%)
Blood n (%) 9 (47.4%)
Urinary tract n (%) 1 (5.3%)
Other n (%) 2 (10.5%)
Pathogens
Gram positive n (%) 5 (26.3%)
Gram negative n (%) 14 (73.7%)
ICU, intensive care unit, SOFA, sequential organ failure assessment. *To notice that
sepsis focus was in 6 cases a mixed focus.
stream infection. While multi-resistant Gram-negative bacteria
were the most represented pathogens, of these four were
Escherichia Coli and two each Pseudomonas Aeruginosa and
Enterobacter Cloacae (Table 1). Median SOFA score at ICU
admission was 11 with mainly respiratory cardiovascular and
hematological dysfunctions. In patients with septic shock the
30-day, ICU and 1-year mortality were 42.1, 52.6, and 63.2%,
respectively (Table 1).
Inflammasome Gene Expression and
mtDNA in Septic Shock Patients and
CTR
The gene expression profile of the entire inflammasome pathway
was evaluated in isolated monocytes from septic patients. Pattern
recognition receptors involved in inflammasomes comprise
nucleotide-binding oligomerization domain and leucine-rich
repeat-containing receptors (NLR) such as NLRP3 and NAIP,
as well as absent in melanoma-2 (AIM-2). Through their
caspase activation and recruitment domain (CARD) or pyrin
domain (PYD), the inflammasome receptors interact with
the adaptor protein ASC, which then recruits pro-caspase-
1 via its CARD domain and activates the effector caspase
through proteolytic cleavage. The activated caspase-1 finally
cleaves the immature pro-inflammatory cytokines pro-IL-
1β and pro-IL-18.
The intracellular levels of main inflammasome mRNAs
was not significantly different in monocytes from patients
of controls, even if a trend toward an increased expression
of PYCARD, AIM2 and NAIP was observed in septic shock
patients (Figures 1A–D). IL-18 and IL-1β gene expression was
higher in patients with septic shock, even if the high variability
among patients did not allow to reach statistical significance
(Figures 1E,F).
Concerning mtDNA, we found that circulating mtDNA levels
were significantly higher in septic shock patients if compared to
controls (Figures 2A,B), and that patients who died in ICU were
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FIGURE 1 | Quantification of inflammasome genes by Real-Time PCR. (A) Quantification of NLRP3 in CD14+ cells on CTR and ICU septic shock patients.
(B) PYCARD, (C) AIM2, (D) NAIP, (E) IL-18, (F) IL-1β. Data are represented as mean ± SEM. Analysis was performed using Mann–Whitney test.
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FIGURE 2 | (A) Representative 2D scatter plot of a ddPCR result, corresponding to mitochondrial (mt)-ND4 of healthy subject (upper panel) and septic patient (lower
panel). The y axis shows FAM fluorescence amplitude of the mt-ND4 probe (channel 1) and the x axis shows the HEX fluorescence amplitude of the EIF2C1 probe
(channel 2). The black cluster represents the negative droplets, the green cluster represents the droplets positive for EIF2C1, the blue cluster represents the droplets
positive for mt-ND4 and the orange cluster represents the droplets that are positive for both targets. (B) Quantification of mtDNA circulating in plasma on CTR and
ICU septic shock patients by ddPCR. Data are represented as mean ± SEM. Analysis was performed using Mann–Whitney test. ***p < 0.05. CTR, controls, ICU,
intensive care unit.
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characterized by higher level of mtDNA if compared to those
patients with septic shock who were then discharged alive from
the ICU (Figures 2A,B). No correlations were found between
mtDNA and inflammasome gene expression level and other
clinical variables reported in Table 1.
DISCUSSION
The spread of bacteria resistant to many classes of antibiotics
is becoming one of the most worrying threats for the scientific
community. The search for prognostic biomarkers during septic
shock is currently the subject of great debate (13). However, few
data exist on the role of inflammatory markers in the prognosis
of septic shock caused by MDR bacteria (14) and, in particular,
no studies investigate the role of inflammasome and mtDNA
in this disease.
Sepsis clearly alters the innate and adaptive immune
responses, causing immune suppression, chronic inflammation,
and finally exhaustion of several cell defense mechanisms.
Understanding how inflammatory processes are orchestrated,
and in particular how their complex mechanisms work together
could pave the way for the identification not only of suitable
therapeutic targets, but also of predictive biomarkers. Here
we observed that patients suffering from septic shock due to
MDR bacteria, if compared to healthy subjects without infection,
are characterized by similar level of inflammasome genes, but
significantly higher level of circulating mtDNA.
Circulating cell-free mtDNA is a functional link between
cell damage, mitochondrial damage and systemic inflammation
and, indeed, mtDNA released after cell death can act as a
DAMP, being able to induce an inflammatory response through
hypomethylated CpG motifs resembling those of bacterial DNA
(15). mtDNA is thus a potent DAMP capable of causing
inflammation and propagating an immune response through its
interaction with TLR9 and inflammasomes (16).
Plasma circulating mtDNA is elevated in critically ill patients,
and increases with age, contributing to the maintenance of
the low-grade, chronic inflammation observed in elderly people
which has been defined “inflammaging” (17).
Results from clinical trials providing data on mtDNA during
sepsis are not conclusive, so it cannot be established if mtDNA is
associated with mortality or not (18). This phenomenon could be
due to several reasons, that even regard technical aspects such as:
(i) the lack of a standardized protocol for the measurements; (ii)
the use of plasma or serum (freshly isolated or frozen); (iii) the
preparation of plasma with or without the presence of platelets,
that contain mitochondria (but not nuclear DNA) and thus can
increase the number of molecules of mtDNA (17). To generate
this data we took advantage of the sophisticated ddPCR approach,
based on partitioning samples in 20,000 or more droplets,
each of them representing an isolated end-point PCR reaction.
Compared to Real-Time PCR, ddPCR provides absolute nucleic
acids quantification and results are less dependent from reaction
efficiency. Beyond technical issues, there is also the question of
the appropriate patient population. Indeed, it is possible that
the mechanism driving mtDNA release differs in patients with
cellular injury from sepsis and those with a mechanical injury, as
seen in phases like post-trauma or post-surgery. Anyway, in our
patients mtDNA was definitely higher in septic shock population,
especially in those who died in the ICU.
Concerning the levels of inflammasome gene expression in
monocytes between septic shock patients and healthy controls,
the hypothesis that MDR patients may have functionally
exhausted the inflammatory response agrees with what stated
by Hotchkiss et al. (19), who described this kind of patients
as an expression of the state of hypo-reactivity of the immune
system in the host’s response to infection. Accordingly, our
data would confirm that patients suffering from septic shock
by MDR pathogens would be in that prevailing phase in which
the inflammatory response has exhausted its thrust, returning
to the levels of a healthy person not affected by an infectious
disease. In other words, we could interpret this as an “abnormal
normality,” i.e., as the functional end of a normal inflammatory
response that should have been much higher in a clinical
situation such as sepsis.
We are aware that it would have been important to study
the inflammasome in cells that are capable of triggering various
inflammatory pathways, such as macrophages, which typically
reside in the tissues. However, we were unable to obtain tissue
samples and had to concentrate on circulating monocytes, which
are simple enough to obtain, and study gene expression rather
than protein levels due to the lack of biological material. In
addition to the inability of studying macrophages we must
also add that unfortunately, only anecdotical reports (20, 21)
have dealt with the role of inflammasomes regarding strains of
resistant bacteria, so our hypothesis of “abnormal normality” has
to be verified with a more conspicuous number of patients.
The high level of mtDNA in patients with septic shock could
also suggest that the exhaustion of inflammasome activity had
favored the progression of the sepsis, and thus allowed the onset
of further cellular damages.
Our study has two important limiting factors represented
by the small size of the sample enrolled and the rather long
period of time elapsed between the beginning and the end of
the study itself. These limiting factors are related to the difficulty
of enrolling patients with septic shock from MDR bacteria with
a microbiological tests’ confirmation obtained within 24 h from
the onset of the shock (most of our patients had bloodstream
infection or secondary or tertiary post-surgical peritonitis). So,
our interest was aimed at testing the level of inflammasome gene
expression and mtDNA at the early onset of the state of shock.
CONCLUSION
In conclusion, even considering the all limitations, our data
suggest that patients with septic shock caused by MDR pathogens
have a relatively low gene expression of inflammasomes, that
is comparable to that of healthy patients without any infection.
Furthermore, we show here that mtDNA could be considered an
early prognostic marker of severity in septic shock from MDR.
Further studies on other, more numerous cohorts are required to
confirm our observations.
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